Non-small cell lung cancer

Volume-Outcome Relationship in Lung Cancer Resection Among Veterans and Non-Veterans

Researchers have investigated the relationship between hospital surgical volume and postoperative outcomes for early-stage non-small cell lung cancer (NSCLC) in Veteran and non-Veteran populations in the United States. The study aimed to evaluate the association between hospital surgical volume and postoperative outcomes, adjusting for relevant patient-, tumor-, and treatment-related covariates.

Cancer

BlossomHill Therapeutics Presents Promising Findings in Phase 1/2 SOLARA Trial for BH-30643 in NSCLC Patients

BlossomHill Therapeutics, a clinical-stage biopharmaceutical company, has presented preliminary findings from the dose escalation portion of its ongoing Phase 1/2 SOLARA trial of BH-30643 in patients with locally advanced or metastatic EGFR-mutant non-small cell lung cancer (NSCLC). BH-30643 is a first-in-class, macrocyclic, non-covalent, mutant selective OMNI-EGFR inhibitor designed to

Non-small cell lung cancer

Personalized Medicine for Cancer Prevention: New Study Finds Electronic Health Records Crucial for Early Detection

A groundbreaking study on personalized medicine for cancer prevention has been published, highlighting the importance of electronic health records (EHRs) in early detection. Researchers at Harvard College developed a prediction model using data from Mass General Brigham's EHR to identify high-risk individuals for non-small cell lung cancer (NSCLC)

Cancer research

Non-Invasive Prediction of EGFR Gene Mutations in NSCLC Using Multi-Parameter CT Perfusion Imaging

Researchers at Nanchang University have made a significant breakthrough in the diagnosis of non-small cell lung cancer (NSCLC) by developing a non-invasive method to predict epidermal growth factor receptor (EGFR) gene mutations. This method uses multi-parameter CT perfusion imaging (CTPI) to analyze blood volume, transit time, and perfusion surface in

Non-small cell lung cancer

Adjuvant Alectinib Offers Substantial Clinical and Economic Value in Non-Small Cell Lung Cancer

A recent study published in the American Journal of Clinical Oncology has found that adjuvant alectinib is a more effective and cost-effective treatment option compared to platinum-based chemotherapy for patients with resectable (stage IB to IIIA) ALK+ non-small cell lung cancer. The study, conducted by researchers at Genentech Inc., evaluated

Non-small cell lung cancer

Immunotherapy Compliance in Non-Small Cell Lung Cancer: Study Reveals Challenges and Opportunities

According to a recent systematic review and meta-analysis, compliance with immunotherapy protocols in non-small-cell lung cancer (NSCLC) remains a significant challenge, particularly in adjuvant and perioperative settings. The study, conducted by a team of researchers from the Department of Cardio-Thoracic and Vascular Surgery at Azienda Ospedaliera-Universitaria Citta della Salute e

Cancer research

LncRNA FEZF1-AS1 Plays Crucial Role in Non-Small Cell Lung Cancer Tumorigenesis and Ferroptosis

Research conducted by scientists at Bengbu Medical University has shed new light on the role of long non-coding RNA (lncRNA) FEZF1-AS1 in non-small cell lung cancer (NSCLC) tumorigenesis and ferroptosis. The study found that FEZF1-AS1 promotes NSCLC progression through suppressing ferroptosis by activating the tumor necrosis factor-alpha (TNF-a)/nuclear factor-kappa

Cancer research

Radiotherapy Combination Therapy Shows Promise in Treating Non-Small Cell Lung Cancer

Research conducted by Qingdao Municipal Hospital in Shandong, People's Republic of China, has shown that combining radiotherapy with anti-angiogenic therapy, immune checkpoint inhibitors, and chemotherapy can be effective in prolonging the survival of patients with advanced non-small cell lung cancer (NSCLC). The study, published in Frontiers in Oncology,

Biochemistry

Definitive Proton Beam Therapy for Second Primary Non-small Cell Lung Cancer After Pneumonectomy Shows Promising Results

Researchers from the University of Tsukuba investigated the outcome of definitive proton beam therapy (PBT) for second primary non-small cell lung cancer occurring in the contralateral lung after pneumonectomy. The study involved 4 patients with squamous cell carcinoma who underwent PBT between January 2006 and December 2019. The patients had

Cancer research

Rare Case of Rectal Metastasis from Primary Lung Adenocarcinoma Reported in New Research

Research published in the World Journal of Surgical Oncology has detailed a rare case of rectal metastasis from an EGFR L858R-mutant primary lung adenocarcinoma. The study describes a 79-year-old male patient who presented with worsening constipation, which led to the discovery of a rectal mass. Initial biopsies revealed chronic rectal

Cancer research

Personalized Medicine for Cancer Prevention: New Study Finds Electronic Health Records Crucial for Early Detection

Cancer research

LncRNA FEZF1-AS1 Plays Crucial Role in Non-Small Cell Lung Cancer Tumorigenesis and Ferroptosis

See all